Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001558370-25-001699
Filing Date
2025-02-27
Accepted
2025-02-27 08:45:34
Documents
131
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K qure-20241231x10k.htm   iXBRL 10-K 3983002
2 EX-4.1 qure-20241231xex4d1.htm EX-4.1 64226
3 EX-10.16 qure-20241231xex10d16.htm EX-10.16 141806
4 EX-10.24 qure-20241231xex10d24.htm EX-10.24 130400
5 EX-14.1 qure-20241231xex14d1.htm EX-14.1 49853
6 EX-19.1 qure-20241231xex19d1.htm EX-19.1 70514
7 EX-21.1 qure-20241231xex21d1.htm EX-21.1 8588
8 EX-23.1 qure-20241231xex23d1.htm EX-23.1 2523
9 EX-31.1 qure-20241231xex31d1.htm EX-31.1 14999
10 EX-31.2 qure-20241231xex31d2.htm EX-31.2 14920
11 EX-32.1 qure-20241231xex32d1.htm EX-32.1 12794
12 GRAPHIC qure-20241231x10k001.jpg GRAPHIC 5737
13 GRAPHIC qure-20241231x10k002.jpg GRAPHIC 35947
14 GRAPHIC qure-20241231xex10d24001.jpg GRAPHIC 9271
15 GRAPHIC qure-20241231xex10d24003.jpg GRAPHIC 35091
16 GRAPHIC qure-20241231xex10d24022.jpg GRAPHIC 75808
  Complete submission text file 0001558370-25-001699.txt   17349985

Data Files

Seq Description Document Type Size
17 EX-101.SCH qure-20241231.xsd EX-101.SCH 105307
18 EX-101.CAL qure-20241231_cal.xml EX-101.CAL 96971
19 EX-101.DEF qure-20241231_def.xml EX-101.DEF 437299
20 EX-101.LAB qure-20241231_lab.xml EX-101.LAB 922746
21 EX-101.PRE qure-20241231_pre.xml EX-101.PRE 714810
134 EXTRACTED XBRL INSTANCE DOCUMENT qure-20241231x10k_htm.xml XML 3233080
Mailing Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP
Business Address PAASHEUVELWEG 25A AMSTERDAM P7 1105 BP 1-339-970-7000
uniQure N.V. (Filer) CIK: 0001590560 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36294 | Film No.: 25673231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)